April 4 is standing tall as the peak day of new coronavirus cases in the US. We’re now 8 days since that date. Looking at data from other countries, shows that in day 10 – 14 from peak the number of new daily cases is around 20% of the peak.

With over 2,000 patients in clinical trials of drugs that have solid promise based on pre-clinical data, those patients will likely be contagious for shorter periods of time reducing the transmissibility and blunting the number of new cases. Also, the prescribing of hydroxychloroquine and azithromycin in early published trials shows elimination of the virus by day 5 whereas patients with no treatment are still positive for 10-12 days. This, too is probably a significant reason for the decline since April 4.

I truly believe pharmaceutical intervention is playing a big role in flattening the curve. Let’s remember that the US pharmaceutical industry is one of America’s greatest assets and is an important part of our excellent and effective healthcare system.